119 related articles for article (PubMed ID: 38195324)
1. Utilization of Autologous Hematopoietic Cell Transplantation Over Time in Multiple Myeloma: A Population-Based Study.
Esteghamat NS; Brunson A; Rosenberg AS; Schonfeld SJ; Valcarcel B; Abrahão R; Cooley JJP; Meyer CL; Auletta JJ; Morton LM; Muffly L; Wun T; Keegan THM
Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e119-e129. PubMed ID: 38195324
[TBL] [Abstract][Full Text] [Related]
2. Utilization and Cost Implications of Hematopoietic Progenitor Cells Stored for a Future Salvage Autologous Transplantation or Stem Cell Boost in Myeloma Patients.
Chhabra S; Thapa B; Szabo A; Konings S; D'Souza A; Dhakal B; Jerkins JH; Pasquini MC; Johnson BD; Hari PN; Hamadani M
Biol Blood Marrow Transplant; 2020 Nov; 26(11):2011-2017. PubMed ID: 32717431
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts.
Adrianzen Herrera D; Kornblum N; Derman O; Bachier-Rodriguez L; Sica RA; Shastri A; Janakiram M; Verma A; Braunschweig I; Mantzaris I
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):516-521. PubMed ID: 31227357
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Autologous Stem Cell Transplantation in Patients with Ultra-High-Risk Multiple Myeloma.
Pasvolsky O; Ghanem S; Milton DR; Masood A; Tanner MR; Bashir Q; Srour S; Saini N; Lin P; Ramdial J; Nieto Y; Lee HC; Patel KK; Kebriaei P; Thomas SK; Weber DM; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH
Transplant Cell Ther; 2023 Dec; 29(12):757-762. PubMed ID: 37673125
[TBL] [Abstract][Full Text] [Related]
5. African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
Badar T; Hari P; Dávila O; Fraser R; Wirk B; Dhakal B; Freytes CO; Rodriguez Valdes C; Lee C; Vesole DH; Malek E; Hildebrandt GC; Landau H; Murthy HS; Lazarus HM; Berdeja JG; Meehan KR; Solh M; Diaz MA; Kharfan-Dabaja MA; Callander NS; Farhadfar N; Bashir Q; Kamble RT; Vij R; Munker R; Kyle RA; Chhabra S; Hashmi S; Ganguly S; Jagannath S; Nishihori T; Nieto Y; Kumar S; Shah N; D'Souza A
Cancer; 2021 Jan; 127(1):82-92. PubMed ID: 32966625
[TBL] [Abstract][Full Text] [Related]
6. Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
Pasvolsky O; Pasyar S; Bassett RL; Khan HN; Tanner MR; Bashir Q; Srour S; Saini N; Lin P; Ramdial J; Nieto Y; Lee HC; Patel KK; Kebriaei P; Thomas SK; Weber DM; Orlowski RZ; Shpall EJ; Champlin RE; Qazilbash MH
Cancer; 2024 May; 130(9):1663-1672. PubMed ID: 38127583
[TBL] [Abstract][Full Text] [Related]
7. Multiple myeloma treatment transformed: a population-based study of changes in initial management approaches in the United States.
Warren JL; Harlan LC; Stevens J; Little RF; Abel GA
J Clin Oncol; 2013 Jun; 31(16):1984-9. PubMed ID: 23569317
[TBL] [Abstract][Full Text] [Related]
8. Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients.
Derman BA; Kordas K; Molloy E; Chow S; Dale W; Jakubowiak AJ; Jasielec J; Kline JP; Kosuri S; Lee SM; Liu H; Riedell PA; Smith SM; Bishop MR; Artz AS
J Geriatr Oncol; 2021 May; 12(4):585-591. PubMed ID: 33162369
[TBL] [Abstract][Full Text] [Related]
9. Length of Stay and Health Care Utilization Among Pediatric Autologous Hematopoietic Cell Transplantation Recipients.
Davis L; Yao Y; Jin Z; Moscoso S; Neunert C; Broglie L; Hall M; Bhatia M; George D; Garvin JH; Satwani P
Transplant Cell Ther; 2021 Jul; 27(7):613.e1-613.e7. PubMed ID: 33831624
[TBL] [Abstract][Full Text] [Related]
10. Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis.
Casulo C; Friedberg JW; Ahn KW; Flowers C; DiGilio A; Smith SM; Ahmed S; Inwards D; Aljurf M; Chen AI; Choe H; Cohen J; Copelan E; Farooq U; Fenske TS; Freytes C; Gaballa S; Ganguly S; Jethava Y; Kamble RT; Kenkre VP; Lazarus H; Lazaryan A; Olsson RF; Rezvani AR; Rizzieri D; Seo S; Shah GL; Shah N; Solh M; Sureda A; William B; Cumpston A; Zelenetz AD; Link BK; Hamadani M
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1163-1171. PubMed ID: 29242111
[TBL] [Abstract][Full Text] [Related]
11. Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades.
Kilari D; D'Souza A; Fraser R; Qayed M; Davila O; Agrawal V; Diaz MA; Chhabra S; Cerny J; Copelan E; Farhadfar N; Freytes CO; Gale RP; Ganguly S; Hildebrandt GC; Holmberg L; Kamble RT; Kapoor P; Lazarus H; Lee C; Murthy HS; Naik S; Nishihori T; Saad A; Savani BN; Seo S; Warwick A; Wirk B; Yared JA; Nieto Y; Hari P
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1099-1106. PubMed ID: 30794931
[TBL] [Abstract][Full Text] [Related]
12. Disparities in Utilization of Autologous Stem Cell Transplantation as Consolidative Therapy for Multiple Myeloma: A Single Institution Retrospective Review.
Lupak O; Xiaoxia H; Xie P; Thanikachalam K; Jabbour-Aida H; Farhan S; Emole J
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):e680-e685. PubMed ID: 34148850
[TBL] [Abstract][Full Text] [Related]
13. Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
Schriber JR; Hari PN; Ahn KW; Fei M; Costa LJ; Kharfan-Dabaja MA; Angel-Diaz M; Gale RP; Ganguly S; Girnius SK; Hashmi S; Pawarode A; Vesole DH; Wiernik PH; Wirk BM; Marks DI; Nishihori T; Olsson RF; Usmani SZ; Mark TM; Nieto YL; D'Souza A
Cancer; 2017 Aug; 123(16):3141-3149. PubMed ID: 28472539
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018.
Valcarcel B; Schonfeld SJ; Meyer CL; Brunson A; Cooley JJP; Abrahão R; Wun T; Auletta JJ; Gadalla SM; Engels E; Albert PS; Spellman SR; Rizzo JD; Shaw BE; Muffly L; Keegan THM; Morton LM
Transplant Cell Ther; 2024 Feb; 30(2):239.e1-239.e11. PubMed ID: 37981238
[TBL] [Abstract][Full Text] [Related]
15. Post-Transplant Outcomes in High-Risk Compared with Non-High-Risk Multiple Myeloma: A CIBMTR Analysis.
Scott EC; Hari P; Sharma M; Le-Rademacher J; Huang J; Vogl D; Abidi M; Beitinjaneh A; Fung H; Ganguly S; Hildebrandt G; Holmberg L; Kalaycio M; Kumar S; Kyle R; Lazarus H; Lee C; Maziarz RT; Meehan K; Mikhael J; Nishihori T; Ramanathan M; Usmani S; Tay J; Vesole D; Wirk B; Yared J; Savani BN; Gasparetto C; Krishnan A; Mark T; Nieto Y; D'Souza A
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1893-1899. PubMed ID: 27496215
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older.
Munshi PN; Vesole DH; St Martin A; Davila O; Kumar S; Qazilbash M; Shah N; Hari PN; D'Souza A
Cancer; 2021 Nov; 127(22):4233-4239. PubMed ID: 34374445
[TBL] [Abstract][Full Text] [Related]
17. Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
Munshi PN; Vesole D; Jurczyszyn A; Zaucha JM; St Martin A; Davila O; Agrawal V; Badawy SM; Battiwalla M; Chhabra S; Copelan E; Kharfan-Dabaja MA; Farhadfar N; Ganguly S; Hashmi S; Krem MM; Lazarus HM; Malek E; Meehan K; Murthy HS; Nishihori T; Olin RL; Olsson RF; Schriber J; Seo S; Shah G; Solh M; Tay J; Kumar S; Qazilbash MH; Shah N; Hari PN; D'Souza A
Cancer; 2020 Dec; 126(23):5077-5087. PubMed ID: 32965680
[TBL] [Abstract][Full Text] [Related]
18. Impact of Thiotepa-Based Autologous Hematopoietic Cell Transplantation in Primary Central Nervous System Lymphoma in First Complete Remission: A University of California Hematologic Malignancies Consortium Retrospective Analysis.
Othman T; Quan MA; Zhang S; Gaut D; Young PA; Mahmood O; Abdulhaq H; Shieh K; Reid J; Brem EA; Hariharan N; Heyman B; Tuscano J
Clin Lymphoma Myeloma Leuk; 2023 Oct; 23(10):749-756. PubMed ID: 37336714
[TBL] [Abstract][Full Text] [Related]
19. Access to hematopoietic stem cell transplantation: effect of race and sex.
Joshua TV; Rizzo JD; Zhang MJ; Hari PN; Kurian S; Pasquini M; Majhail NS; Lee SJ; Horowitz MM
Cancer; 2010 Jul; 116(14):3469-76. PubMed ID: 20564154
[TBL] [Abstract][Full Text] [Related]
20. Health Care Reimbursement, Service Utilization, and Outcomes among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings.
Dunavin N; Mau LW; Meyer CL; Divine C; Abdallah AO; Leppke S; D'Souza A; Denzen E; Saber W; Burns LJ; Ganguly S
Biol Blood Marrow Transplant; 2020 Apr; 26(4):805-813. PubMed ID: 31917269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
